Regorafenib or rechallenge chemotherapy: which is more...

  • Main
  • 2018 / 10
  • Regorafenib or rechallenge chemotherapy: which is more...
Cancer Chemotherapy and Pharmacology 2018 / 10

Regorafenib or rechallenge chemotherapy: which is more effective in the third-line treatment of metastatic colorectal cancer?

Köstek, Osman, Hacıoğlu, Muhammet Bekir, Sakin, Abdullah, Demir, Tarık, Sarı, Murat, Ozkul, Ozlem, Araz, Murat, Doğan, Aysun Fatma, Demircan, Nazım Can, Uzunoğlu, Sernaz, Çiçin, İrfan, Erdoğan, Bülent
How much do you like this book?
What’s the quality of the file?
Download the book for quality assessment
What’s the quality of the downloaded files?
Language:
english
Journal:
Cancer Chemotherapy and Pharmacology
DOI:
10.1007/s00280-018-3713-6
Date:
October, 2018
File:
PDF, 722 KB
english, 2018
Conversion to is in progress
Conversion to is failed